Literature DB >> 4967459

Systemic lupus erythematosus. Occurrence in association with ethosuximide therapy.

S Livingston, H Rodriguez, C A Greene, L L Pauli.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 4967459     DOI： 10.1001/jama.203.8.731

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  5 in total

1.  Antinuclear antibodies in patients on anticonvulsant therapy.

Authors:  D Alarcón-Segovia; E Fishbein; P A Reyes; H Díes; S Shwadsky
Journal:  Clin Exp Immunol       Date:  1972-09       Impact factor: 4.330

2.  Lupus-scleroderma syndrome induced by ethosuximide.

Authors:  P C Teoh; H L Chan
Journal:  Arch Dis Child       Date:  1975-08       Impact factor: 3.791

Review 3.  Antiepileptic drug toxicity: definition and mechanism of action.

Authors:  E Beghi; R Di Mascio
Journal:  Ital J Neurol Sci       Date:  1986-04

Review 4.  Systemic lupus erythematosus (SLE)-like syndromes associated with carbamazepine therapy.

Authors:  K K Jain
Journal:  Drug Saf       Date:  1991 Sep-Oct       Impact factor: 5.606

Review 5.  Recent advances in the immunopathogenesis of systemic lupus erythematosus.

Authors:  E J Bardana; B Pirofsky
Journal:  West J Med       Date:  1975-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.